Palatin Technologies
PTN
#10723
Rank
ยฃ10.14 M
Marketcap
ยฃ5.70
Share price
-1.41%
Change (1 day)
N/A
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2026 (TTM): -ยฃ4.62 Million

According to Palatin Technologies's latest financial reports the company's current earnings are ยฃ12.88 Million. In 2025 the company made an earning of -ยฃ7.13 Million, an increase over its 2024 earnings that were of -ยฃ19.96 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ4.62 Million-35.23%
2025 -ยฃ7.13 Million-64.29%
2024 -ยฃ19.96 Million-16.9%
2023 -ยฃ24.02 Million5.99%
2022 -ยฃ22.66 Million-13.7%
2021 -ยฃ26.26 Million33.25%
2020 -ยฃ19.7 Million-172.11%
2019 ยฃ27.31 M2352.33%
2018 ยฃ1.11 M-94.13%
2017 ยฃ18.98 M-154.92%
2016 -ยฃ34.57 Million3.67%
2015 -ยฃ33.35 Million878%
2014 -ยฃ3.41 Million-72.64%
2013 -ยฃ12.46 Million-33.11%
2012 -ยฃ18.63 Million77.71%
2011 -ยฃ10.49 Million
2003 -ยฃ17.75 Million29.93%
2002 -ยฃ13.67 Million36.18%
2001 -ยฃ10.04 Million
1999 -ยฃ8.33 Million6.04%
1998 -ยฃ7.86 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.24 B-416,306.07%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ10.86 B-235,029.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
ยฃ0.59 B-12,897.47%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-ยฃ8.68 Million 87.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ0.14 B-3,151.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-ยฃ87.15 Million 1,784.89%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
ยฃ85.94 M-1,958.82%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-ยฃ21.85 Million 372.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-ยฃ42.92 Million 828.28%๐Ÿ‡บ๐Ÿ‡ธ USA